Americans who qualify for Medicare coverage because of a disability, end-stage kidney disease or amyotrophic lateral sclerosis, can choose their health insurance coverage for 2025 — whether that's a ...
Novartis AG’s best-selling drug and a key new cancer medicine posted disappointing sales last quarter, even as the Swiss drugmaker lifted profit guidance for a third straight quarter.
The "Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's offering. Antibody drug conjugates ...